Legend Biotech Announces Participation in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
SOMERSET, N.J.--(BUSINESS WIRE)--
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:
Event: Citi's 17th Annual BioPharma Conference Location:Boston, Massachusetts Fireside Chat Date & Time: Wednesday, September 7, 2022 at 11:20am ET Presenter: Ying Huang, Ph.D., CEO
Event: 2022 Wells Fargo Healthcare Conference Location:Boston, Massachusetts Fireside Chat Date & Time: Thursday, September 8, 2022 at 2:35pm ET Presenter: Ying Huang, Ph.D., CEO
Event:Morgan Stanley Global Healthcare Conference 2022
Location:New York, New York Fireside Chat Date & Time: Monday, September 12, 2022 at 3:40pm ET Presenter:Ying Huang, Ph.D., CEO
Event:Jefferies Cell and Genetic Medicine Summit
Location:New York, New York Date: September 29 & 30, 2022
About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
